Safety and Efficacy of Bexagliflozin in Subjects With Moderate Hepatic Impairment

Summary

The purpose of this study is to examine the drug exposure and drug effects on subjects with moderate hepatic impairment after a single oral dose of bexagliflozin tablets, 20mg. The study will also evaluate how safe the study drug is and how well the study drug is tolerated in subjects with moderate hepatic impairment.

Timeline

Start

2018-07-26

Primary completion

2018-12-26

Completion

2018-12-26

Drugs

Indications